Cloves Syndrome Awareness Day

United States, Canada, United Kingdom, Australia

About

Cloves Syndrome Awareness Day, observed on August 3, helps shine a light on CLOVES syndrome, a rare congenital disorder involving the overgrowth of fatty tissue, blood vessels, lymphatic vessels, and bones. The condition can affect individuals in different ways, making awareness and understanding especially important for patients, families, caregivers, and healthcare professionals.

The observance celebrates the strength and resilience of people living with CLOVES syndrome while encouraging compassion, education, and support. August 3 offers an opportunity to learn more about this rare condition, recognize the challenges families may face, and help build a more informed and inclusive community for everyone affected.

History

Cloves Syndrome Awareness Day is observed annually on August 3 to increase understanding of CLOVES syndrome, a rare congenital disorder. The name “CLOVES” is an acronym for Congenital Lipomatous Overgrowth, Vascular Malformations, Epidermal Nevi, and Skeletal or spinal abnormalities—the range of features that can occur in affected individuals. Because the condition is uncommon and presents differently from person to person, awareness efforts emphasize accurate recognition, compassionate care, and the needs of patients and their families.

The medical understanding of CLOVES syndrome developed relatively recently. Although some of its physical characteristics had been described separately in earlier medical literature, researchers began identifying a distinct pattern involving fatty-tissue overgrowth, vascular anomalies, skin changes, and musculoskeletal abnormalities. The term “CLOVES syndrome” was introduced in the late 2000s, helping physicians and researchers distinguish it from other overgrowth and vascular-malformation conditions. This clearer classification supported more focused diagnosis, research, and treatment.

The observance grew out of advocacy by patients, parents, medical professionals, and organizations connected with rare-disease communities. On August 3, awareness campaigns commonly share educational information, personal experiences, and resources about diagnosis and multidisciplinary treatment. They also help explain that CLOVES syndrome is not contagious and that its effects can vary significantly, ranging from visible differences and limb asymmetry to pain, mobility challenges, vascular complications, or spinal involvement.

Culturally, Cloves Syndrome Awareness Day reflects the broader rare-disease movement’s emphasis on visibility and inclusion. It gives individuals living with CLOVES syndrome an opportunity to be represented beyond their medical condition while encouraging the public to respond to difference with understanding rather than misconception. By setting aside August 3 for education and advocacy, the observance supports earlier recognition, stronger patient communities, and continued efforts to improve long-term care and quality of life.

Timeline

2009
Ahmed I. Alomari and colleagues described and named CLOVES syndrome, an acronym for congenital lipomatous overgrowth, vascular malformations, epidermal nevi, and skeletal/spinal anomalies.
2012
Researchers reported that somatic mosaic activating mutations in the PIK3CA gene cause CLOVES syndrome, establishing its molecular basis.
2022
The U.S. Food and Drug Administration granted accelerated approval to alpelisib (Vijoice) for patients aged 2 years and older with severe manifestations of PIK3CA-related overgrowth spectrum, the group of disorders that includes CLOVES syndrome.

Upcoming dates

Sources

Same day

Related